May 23, 2013 05:21PM Amgen to Present at the Deutsche Bank 38th Annual Healthcare Conference
May 22, 2013 05:46PM Amgen Announces Voting Results of Annual Meeting of Stockholders
May 16, 2013 04:18PM Amgen To Present At The UBS Global Life Sciences Conference
May 15, 2013 06:02PM New Analyses Identify Predictive Biomarkers For Vectibix® (Panitumumab) In Patients With Metastatic Colorectal Cancer
May 15, 2013 06:00PM Amgen Highlights Data To Be Presented At American Society of Clinical Oncology Annual Meeting
May 9, 2013 04:08PM Amgen And Zhejiang Beta Pharma Announce Planned Joint Venture In China
May 7, 2013 04:04PM Amgen Announces Top-Line Results of Vectibix® (panitumumab) Phase 3 Head-to-Head Study Against Erbitux® (cetuximab) in Metastatic Colorectal Cancer
May 1, 2013 04:05PM Four Californians Selected as Breakaway from Cancer® Champions to be Honored During Amgen Tour of California
Apr 23, 2013 04:00PM Amgen's First Quarter 2013 Revenues Increased 5 Percent To $4.2 Billion And Adjusted Earnings Per Share (EPS) Increased 22 Percent To $1.96
Apr 18, 2013 04:16PM Amgen Announces Webcast of 2013 First Quarter Financial Results